← Back to headlines
Teva's Biosimilar Business Shows Growth Potential, Attracting Investor Interest
Teva Pharmaceutical Industries is experiencing a boom in its biosimilar business, leading to speculation among investors about the potential for its rebounding stock.
12 Jun, 20:25 — 12 Jun, 20:25
Sources
Showing 1 of 1 sources
